[Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D005078:Exchange Transfusion, Whole Blood; D005164:Factor IX / Q000037:antagonists & inhibitors; D005167:Factor VII / Q000037:antagonists & inhibitors; D005169:Factor VIII / Q000037:antagonists & inhibitors; D005170:Factor X / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007223:Infant; D008297:Male
D000925:Anticoagulants; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D005167:Factor VII; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X
Aktivitätssteigerungen verminderter Gerinnungsfaktoren bei angeborenen Gerinnungsdefekten.